Skip to main content
Imaflex logo

Imaflex — Investor Relations & Filings

Ticker · IFX ISIN · CA4524352099 LEI · 549300T8WJFE3P8UEK30 TSXV Manufacturing
Filings indexed 256 across all filing types
Latest filing 2025-05-27 Regulatory Filings
Country CA Canada
Listing TSXV IFX

Imaflex Inc. develops, manufactures, and sells innovative flexible packaging materials and specialized agricultural films. The company focuses on producing polyethylene (PE) films, including blown polyethylene and metallized flexible films, tailored for client needs in the packaging industry. Imaflex is a recognized leader in agricultural film technology, offering products such as Mulch, Solarization & Fumigation Films, and Crop Protection Films. A core technological capability involves the creation and manufacturing of proprietary additive concentrates for all polyolefin film products, ensuring customized performance for specific applications. The product portfolio also includes Converter Films and Industrial Bags.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is FORM 52-109FV2, a CEO certification of interim filings (interim financial report and interim MD&A) under Canadian Regulation 52-109 for a venture issuer. It is not the interim financial report itself (IR) nor a Management Discussion & Analysis (MDA), but rather the regulatory certification that must accompany those filings. No specific category covers a certification form, so it defaults to a general regulatory filing.
2025-05-27 English
52-109FV2 - Certification of interim filings - CFO (F).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109AE2 attestation by the CFO for the interim financial report and interim management report for the quarter ended March 31, 2025 under Canadian securities rules. It is not the full interim report itself but a standalone regulatory certification form. Since it does not fit any of the specific categories (e.g., full Interim/Quarterly Report, Management Discussion & Analysis, etc.), it falls into the general regulatory filings fallback category (RNS).
2025-05-27 French
52-109FV2 - Certification of interim filings - CEO (F).pdf
Regulatory Filings Classification · 1% confidence The document is an attestation under Regulation 52-109 by the CEO of Imaflex Inc. regarding the interim financial and management reports for the quarter ended March 31, 2025. It is not the interim report itself but a certification/attestation filing required by securities regulations. This does not match categories like Interim Report (which covers the actual financials), Earnings Release, or any specific transaction or governance announcement. It is a regulatory compliance filing, best classified under the fallback “Regulatory Filings” category (RNS).
2025-05-27 French
Interim MD&A - French.pdf
Management Reports Classification · 1% confidence The document is titled “Rapport de gestion” and provides Management’s Discussion and Analysis (MD&A) for the interim periods ended March 31, 2025 and 2024, including business strategy, financial performance commentary, forward-looking statements, accounting policies, and discussion of results. It is an in-depth management report meant to be read alongside the interim financial statements. This aligns precisely with the definition of Management Reports (MDA).
2025-05-27 French
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management Discussion and Analysis” for the first quarter of 2025, providing narrative commentary on operations, financial performance, condition, outlook and critical accounting policies. It clearly matches the definition of a Management Discussion and Analysis (Management Reports, Code: MDA) rather than a full interim report, earnings release or other category. Therefore, it should be classified as Code MDA.
2025-05-27 English
Interim financial statements/report – French.pdf
Interim / Quarterly Report Classification · 1% confidence The document contains unaudited interim consolidated financial statements for Imaflex Inc. for the quarters ended March 31, 2025, and 2024. It includes a consolidated statement of comprehensive income, statement of financial position, statement of changes in equity, statement of cash flows, and detailed notes to the financial statements. This meets the definition of a comprehensive financial report for a period shorter than a full fiscal year. Q1 2025
2025-05-27 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.